Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 112

1.

BI-RADS® 3 lesions at contrast-enhanced breast MRI: is an initial short-interval follow-up necessary?

Bahrs SD, Baur A, Hattermann V, Hahn M, Vogel U, Claussen CD, Siegmann-Luz KC.

Acta Radiol. 2014 Apr;55(3):260-5. doi: 10.1177/0284185113501304. Epub 2013 Aug 22.

PMID:
23969262
[PubMed - indexed for MEDLINE]
2.

BI-RADS lesion characteristics predict likelihood of malignancy in breast MRI for masses but not for nonmasslike enhancement.

Gutierrez RL, DeMartini WB, Eby PR, Kurland BF, Peacock S, Lehman CD.

AJR Am J Roentgenol. 2009 Oct;193(4):994-1000. doi: 10.2214/AJR.08.1983.

PMID:
19770321
[PubMed - indexed for MEDLINE]
3.

Characteristics of probably benign breast MRI lesions.

Eby PR, DeMartini WB, Gutierrez RL, Saini MH, Peacock S, Lehman CD.

AJR Am J Roentgenol. 2009 Sep;193(3):861-7. doi: 10.2214/AJR.08.2096.

PMID:
19696303
[PubMed - indexed for MEDLINE]
4.

Breast MRI as an adjunct to mammography: Does it really suffer from low specificity? A retrospective analysis stratified by mammographic BI-RADS classes.

Benndorf M, Baltzer PA, Vag T, Gajda M, Runnebaum IB, Kaiser WA.

Acta Radiol. 2010 Sep;51(7):715-21. doi: 10.3109/02841851.2010.497164.

PMID:
20707656
[PubMed - indexed for MEDLINE]
5.

Role of magnetic resonance imaging in probably benign (BI-RADS category 3) microcalcifications of the breast.

Linda A, Zuiani C, Londero V, Di Gaetano E, Dal Col A, Girometti R, Bazzocchi M.

Radiol Med. 2014 Jun;119(6):393-9. doi: 10.1007/s11547-013-0361-0. Epub 2013 Dec 3.

PMID:
24297595
[PubMed - indexed for MEDLINE]
6.

Contrast-enhanced MR imaging in patients with BI-RADS 3-5 microcalcifications.

Cilotti A, Iacconi C, Marini C, Moretti M, Mazzotta D, Traino C, Naccarato AG, Piagneri V, Giaconi C, Bevilacqua G, Bartolozzi C.

Radiol Med. 2007 Mar;112(2):272-86. Epub 2007 Mar 19. English, Italian.

PMID:
17361370
[PubMed - indexed for MEDLINE]
7.

False-positive findings at contrast-enhanced breast MRI: a BI-RADS descriptor study.

Baltzer PA, Benndorf M, Dietzel M, Gajda M, Runnebaum IB, Kaiser WA.

AJR Am J Roentgenol. 2010 Jun;194(6):1658-63. doi: 10.2214/AJR.09.3486.

PMID:
20489110
[PubMed - indexed for MEDLINE]
8.

Background parenchymal enhancement on baseline screening breast MRI: impact on biopsy rate and short-interval follow-up.

Hambly NM, Liberman L, Dershaw DD, Brennan S, Morris EA.

AJR Am J Roentgenol. 2011 Jan;196(1):218-24. doi: 10.2214/AJR.10.4550.

PMID:
21178070
[PubMed - indexed for MEDLINE]
9.

Contrast-enhanced MR mammography for evaluation of the contralateral breast in patients with diagnosed unilateral breast cancer or high-risk lesions.

Pediconi F, Catalano C, Roselli A, Padula S, Altomari F, Moriconi E, Pronio AM, Kirchin MA, Passariello R.

Radiology. 2007 Jun;243(3):670-80. Epub 2007 Apr 19.

PMID:
17446524
[PubMed - indexed for MEDLINE]
10.

Invasive lobular carcinoma of the breast: MRI pathological correlation following bilateral total mastectomy.

Stivalet A, Luciani A, Pigneur F, Dao TH, Beaussart P, Merabet Z, Perlbarg J, Meyblum E, Baranes L, Calitchi E, Lepage C, Belkacemi Y, Lagrange JL, Lantieri L, Rahmouni A.

Acta Radiol. 2012 May 1;53(4):367-75. doi: 10.1258/ar.2012.110477.

PMID:
22553225
[PubMed - indexed for MEDLINE]
11.

Contrast-enhanced 3.0-T breast MRI for characterization of breast lesions: increased specificity by using vascular maps.

Schmitz AC, Peters NH, Veldhuis WB, Gallardo AM, van Diest PJ, Stapper G, van Hillegersberg R, Mali WP, van den Bosch MA.

Eur Radiol. 2008 Feb;18(2):355-64. Epub 2007 Sep 20.

PMID:
17882425
[PubMed - indexed for MEDLINE]
12.

Probability of malignancy for lesions detected on breast MRI: a predictive model incorporating BI-RADS imaging features and patient characteristics.

Demartini WB, Kurland BF, Gutierrez RL, Blackmore CC, Peacock S, Lehman CD.

Eur Radiol. 2011 Aug;21(8):1609-17. doi: 10.1007/s00330-011-2094-6. Epub 2011 Feb 27.

PMID:
21359910
[PubMed - indexed for MEDLINE]
13.

Magnetic resonance imaging of primary breast lymphoma.

Rizzo S, Preda L, Villa G, Brambilla S, Pruneri G, Alietti A, Cassano E, Martinelli G, Bellomi M.

Radiol Med. 2009 Sep;114(6):915-24. doi: 10.1007/s11547-009-0420-8. Epub 2009 Jun 26. English, Italian.

PMID:
19562266
[PubMed - indexed for MEDLINE]
14.

Dynamic contrast-enhanced MR imaging in screening detected microcalcification lesions of the breast: is there any value?

Uematsu T, Yuen S, Kasami M, Uchida Y.

Breast Cancer Res Treat. 2007 Jul;103(3):269-81. Epub 2006 Oct 25.

PMID:
17063274
[PubMed - indexed for MEDLINE]
15.

Frequency of malignancy seen in probably benign lesions at contrast-enhanced breast MR imaging: findings from ACRIN 6667.

Weinstein SP, Hanna LG, Gatsonis C, Schnall MD, Rosen MA, Lehman CD.

Radiology. 2010 Jun;255(3):731-7. doi: 10.1148/radiol.10081712.

PMID:
20501712
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Positive predictive value of BI-RADS MR imaging.

Mahoney MC, Gatsonis C, Hanna L, DeMartini WB, Lehman C.

Radiology. 2012 Jul;264(1):51-8. doi: 10.1148/radiol.12110619. Epub 2012 May 15.

PMID:
22589320
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Combined contrast-enhanced magnetic resonance and diffusion-weighted imaging reading adapted to the "Breast Imaging Reporting and Data System" for multiparametric 3-T imaging of breast lesions.

Pinker K, Bickel H, Helbich TH, Gruber S, Dubsky P, Pluschnig U, Rudas M, Bago-Horvath Z, Weber M, Trattnig S, Bogner W.

Eur Radiol. 2013 Jul;23(7):1791-802. doi: 10.1007/s00330-013-2771-8. Epub 2013 Mar 16.

PMID:
23504036
[PubMed - indexed for MEDLINE]
18.

Use of BI-RADS 3-probably benign category in the American College of Radiology Imaging Network Digital Mammographic Imaging Screening Trial.

Baum JK, Hanna LG, Acharyya S, Mahoney MC, Conant EF, Bassett LW, Pisano ED.

Radiology. 2011 Jul;260(1):61-7. doi: 10.1148/radiol.11101285. Epub 2011 Apr 18.

PMID:
21502382
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

[Diagnostic value of a breast MRI score for the prediction of malignancy of breast lesions detected solely with MRI].

Siegmann KC, Moron HU, Baur A, Hahn M, Vogel U, Claussen CD, Bitzer M.

Rofo. 2009 Jun;181(6):556-63. doi: 10.1055/s-0028-1109156. Epub 2009 May 18. German.

PMID:
19452398
[PubMed - indexed for MEDLINE]
20.

MR imaging in probably benign lesions (BI-RADS category 3) of the breast.

Gökalp G, Topal U.

Eur J Radiol. 2006 Mar;57(3):436-44. Epub 2005 Nov 28.

PMID:
16316732
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk